Tests of data quality, scaling assumptions, reliability, and construct validity of the SF-36 health survey in people who abuse heroin

Journal of the Formosan Medical Association

Volumn 113, Issue 4, 2014, Pages 234-241

  Chiu, En Chi ^a   Hsueh, I Ping ^a,b   Hsieh, Cheng Hsi ^c   Hsieh, Ching Lin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Druge abuse; Health status indicators; Heroin; Psychometrics; Quality of life

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; CONSTRUCT VALIDITY; CONVERGENT VALIDITY; CRONBACH ALPHA COEFFICIENT; DATA ANALYSIS; DRUG ABUSE; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDIMENSIONAL SCALING; PAIN ASSESSMENT; QUALITY CONTROL PROCEDURES; SHORT FORM 36; SOCIAL INTERACTION TEST; TEST RETEST RELIABILITY; YOUNG ADULT; HEALTH SURVEY; HEROIN DEPENDENCE; METHODOLOGY; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; REPRODUCIBILITY; VALIDATION STUDY;

ADULT; FEMALE; HEALTH SURVEYS; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 84897113196     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2012.05.010     Document Type: Article

References (41)

1. First M.B., Tasman A. DSM-IV-TR Mental disorders: diagnosis, etiology, and treatment 2004, John Wiley & Sons, Ltd, London, UK.
2. Kwiatkowski C.F., Fortuin Corsi K., Booth R.E. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 2002, 97:1289-1294.
3. Quaglio G.L., Lugoboni F., Pajusco B., Sarti M., Talamini G., Mezzelani P., et al. Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy. J Viral Hepat 2003, 10:394-400.
4. Chitwood D.D., Comerford M., Sanchez J. Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin. J Psychoactive Drugs. 2003, 35:445-453.
5. Mark T.L., Woody G.E., Juday T., Kleber H.D. The economic costs of heroin addiction in the United States. Drug Alcohol Depend 2001, 61:195-206.
6. Torrens M., San L., Martinez A., Castillo C., Domingo-Salvany A., Alonso J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1997, 92:707-716.
7. Maremmani I., Pani P., Pacini M., Perugi G. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat 2007, 33:91-98.
8. Kamphuis M., Ottenkamp J., Vliegen H.W., Vogels T., Zwinderman K.H., Kamphuis R.P., et al. Health related quality of life and health status in adult survivors with previously operated complex congenital heart disease. Heart 2002, 87:356-362.
9. Wilson K.C., Saukkonen J.J. Acute respiratory failure from abused substances. J Intensive Care Med 2004, 19:183-193.
10. Roszler M.H., McCarroll K.A., Donovan K.R., Rashid T., Kling G.A. The groin hit: complications of intravenous drug abuse. Radiographics 1989, 9:487-508.
11. Jaffe R.B., Koschmann E.B. Intravenous drug abuse. Pulmonary, cardiac, and vascular complications. Am J Roentgenol Radium Ther Nucl Med 1970, 109:107-120.
12. Yen C.-N., Wang C.S.-M., Wang T.-Y., Chen H.-F., Chang H.-C. Quality of life and its correlates among heroin users in Taiwan. Kaohsiung J Med Sci 2011, 27:177-183.
13. De Maeyer J., Vandeplasschen W., Broekaert E. Quality of life among opiate-dependent individuals: A review of the literature. Int J Drug Policy 2010, 31:364-380.
14. Gonzalez-Saiz F., Rojas O.L., Castillo Measuring the impact of psychoactive substance on health-related quality of life: an update. Curr Drug Abuse Rev 2009, 2:5-10.
15. Domingo-Salvany A., Brugal M.T., Barrio G., Gonzalez-Saiz F., Bravo M.J., de la Fuente L. Gender differences in health related quality of life of young heroin users. Health Qual Life Outcomes 2010, 8:145.
16. De Maeyer J., Vanderplasschen W., Lammertyn J., van Nieuwenhuizen C., Broekaert E. Exploratory study on domain-specific determinants of opiate-dependent individuals' quality of life. Eur Addict Res 2011, 17:198-210.
17. Ponizovsky A.M., Grinshpoon A. Quality of life among heroin users on buprenorphine versus methadone maintenance. Am J Drug Alcohol Abuse 2007, 33:631-642.
18. Bjorner J.B., Thunedborg K., Kristensen T.S., Modvig J., Bech P. The Danish SF-36 Health Survey: translation and preliminary validity studies. J Clin Epidemiol 1998, 51:991-999.
19. Hobart J.C., Riazi A., Lamping D.L., Fitzpatrick R., Thompson A.J. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 2004, 8:1-48.
20. Hobart J.C., Lamping D.L., Thompson A.J. Evaluating neurological outcome measures: the bare essentials. J Neurol Neurosurg Psychiatr 1996, 60:127-130.
21. Uherick L., Gorelick M.H., Biechler R., Brixey S.N., Melzer-Lange M. Validation of two child passenger safety questionnaires. Inj Prev 2010, 16:343-347.
22. Cramm J.M., Strating M.M.H., Nieboer A.P. Validation of the caregivers' satisfaction with stroke care questionnaire: C-SASC hospital scale. J Neurol 2011, 258:1008-1012.
23. Sullivan M., Karlsson J., Ware J.E. The swedish SF-36 health survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sco Med 1995, 41:1349-1358.
24. Loge J.H., Kaasa S., Hjermstad M.J., Kvien T.K. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998, 51:1069-1076.
25. Lim L.L., Seubsman S.A., Sleigh A. Thai SF-36 health survey: tests of data quality, scaling assumptions, reliability and validity in healthy men and women. Health Qual Life Outcomes 2008, 18:52.
26. Fuh J.-L., Wang S.-J., Lu S.-R., Juang K.-D., Lee S.-J. Psychometric evaluation of a Chinese (Taiwanese) version of the SF-36 health survey amongst middle-aged women from a rural community. Qual Life Res 2000, 9:675-683.
27. Riazi A., Hobart J.C., Lamping D.L., Fitzpatrick R., Thompson A.J. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 2002, 73:701-704.
28. Ware J.E., Kosinski M., Gandek B. SF-36 health suvery: maunal & interpretation guide 1993, QualityMertic Incorporated, Lincoln, RI, 2000.
29. Lu H.-F., Tseng H.-M., Tsai Y.-J. Assessment of health-related quality of life in Taiwan (I): development and psychometric testing of SF-36 Taiwan version. Taiwan J Public Health 2002, 22:501-511. [in Chinese].
30. Gandek B., Ware J.E., Aaronson N.K., Alonso J., Apolone G., Bjorner J., et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA project. J Clin Epidemiol 1998, 51:1149-1158.
31. Ware J.E., Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA project approach. J Clin Epidemiol 1998, 11:945-952.
32. Holmes W.C., Shea J.A. Performance of a new, HIV/AIDS-targeted quality of life (HAT-QoL) instrument in asymptomatic seropositive individuals. Qual Life Res 1997, 6:561-571.
33. Gandek B., Ware J.E. Methods for tesing data quality, scaling assumptions, and realibility: the IQOLA project approach. J Clin Epidemiol 1998, 51:945-952.
34. McHorney C.A., Ware J.E., Lu R., Sherbourne C.D. The MOS-item short-form halth survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40-66.
35. Nunnally J.C. Psychometric theory 1978, McGraw-Hill, New York. 2nd ed.
36. McHorney C.A., Ware J.E., Raczek A.E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263.
37. Ware J.E., Gandek B. Overview of the SF-36 Healthy Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998, 51:903-912.
38. Likert R.A. A technique for the development of attitudes. Arch Psychol 1932, 140:5-55.
39. Skinner H.A., Lei H. Differential weights in life change research: useful or irrelevant?. Psychosomatic Med 1980, 42:367-370.
40. Zhou B., Chen K., Wang J.F., Wu Y.Y., Zheng W.J., Wang H. Reliability and validity of a Short-Form Health Survey Scale (SF-36), Chinese version used in an elderly population of Zhejiang province in China. Zhonghua Liu Xing Bing Xue Za Zhi 2008, 29:1993-1998. [in Chinese].
41. Lam C.L., Gandek B., Ren X.S., Chan M.S. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol 1998, 51:1139-1147.